[Federal Register: February 29, 2008 (Volume 73, Number 41)]
[Notices]
[Page 11149-11150]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29fe08-109]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on January 23, 2008, Stepan
Company, Natural Products Dept., 100 W. Hunter Avenue, Maywood, New
Jersey 07607, made application by renewal to the Drug Enforcement
Administration (DEA) as a bulk manufacturer of the basic classes of
controlled substances listed in schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Coca Leaves (9040)......................... II
Cocaine (9041)............................. II
Benzoylecgonine (9180)..................... II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration pursuant to 21 CFR
1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Drug Enforcement
Administration, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537, or any being sent via
express mail should be sent to Drug Enforcement Administration, Office
of Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152, and must be filed no
later than April 29, 2008.
[[Page 11150]]
Dated: February 20, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-3875 Filed 2-28-08; 8:45 am]
BILLING CODE 4410-09-P